Showing results (31-40 of 47) with videos related to
Sort By:
Pageof 5
ESMO Open|October 12, 2024
Clinical relevance of reports on early access programs for checkpoint inhibitors in cancer patients: a French retrospective nationwide cohort studyA Chatain, C Fenioux, G Lamé, et al.La Revue De Medecine Interne|January 1, 1997
[Oxaliplatin, folinic acid and 5-fluorouracil (folfox) in pretreated patients with metastatic advanced cancer. The GERCOD]A de Gramont, C Tournigand, C Louvet, et al.Clinical Nutrition (Edinburgh, Scotland)|June 22, 2013
Geriatric syndromes increased the nutritional risk in elderly cancer patients independently from tumour site and metastatic status. The ELCAPA-05 cohort studyE Paillaud, E Liuu, M Laurent, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 12, 2013
Combined HER2 analysis of biopsies and surgical specimens to optimize detection of trastuzumab-eligible patients in eso-gastric adenocarcinoma: a GERCOR studyS Watson, P Validire, P Cervera, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 13, 2006
Phase II study of an optimized 5-fluorouracil-oxaliplatin strategy (OPTIMOX2) with celecoxib in metastatic colorectal cancer: a GERCOR studyT André, C Tournigand, L Mineur, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 21, 2009
Efficacy of FOLFIRI-3 (irinotecan D1,D3 combined with LV5-FU) or other irinotecan-based regimens in oxaliplatin-pretreated metastatic colorectal cancer in the GERCOR OPTIMOX1 studyF-C Bidard, C Tournigand, T André, et al.European Journal of Cancer (Oxford, England : 1990)|December 13, 2012
Supportive care organisation in France: an in depth study by the French speaking association for supportive care in cancer (AFSOS)F Scotté, C Hervé, S Oudard, et al.European Journal of Cancer (Oxford, England : 1990)|December 12, 2018
Oxaliplatin, 5-Fluorouracil and Nab-paclitaxel as perioperative regimen in patients with resectable gastric adenocarcinoma: A GERCOR phase II study (FOXAGAST)S Watson, C de la Fouchardière, S Kim, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 6, 2001
Evaluation of oxaliplatin dose intensity in bimonthly leucovorin and 48-hour 5-fluorouracil continuous infusion regimens (FOLFOX) in pretreated metastatic colorectal cancer. Oncology Multidisciplinary Research Group (GERCOR)F Maindrault-Goebel, A de Gramont, C Louvet, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 21, 2004
Gemcitabine combined with oxaliplatin (GEMOX) in advanced biliary tract adenocarcinoma: a GERCOR studyT André, C Tournigand, O Rosmorduc, et al.Pageof 5